Published in Int J Biochem Cell Biol on July 22, 2011
Repression of miR-143 mediates Cr (VI)-induced tumor angiogenesis via IGF-IR/IRS1/ERK/IL-8 pathway. Toxicol Sci (2013) 0.90
Cell cycle progression in response to oxygen levels. Cell Mol Life Sci (2014) 0.82
Hypoxia-Inducible Factor (HIF) as a Pharmacological Target for Prevention and Treatment of Infectious Diseases. Infect Dis Ther (2014) 0.82
hypoxia-inducible factors activate CD133 promoter through ETS family transcription factors. PLoS One (2013) 0.78
Molecular Characterization and Expression Analysis of S6K1 in Cashmere Goats (Capra hircus). Asian-Australas J Anim Sci (2013) 0.75
Association of Hypoxia-Inducible Factor-2 Alpha Gene Polymorphisms with the Risk of Hepatitis B Virus-Related Liver Disease in Guangxi Chinese: A Case-Control Study. PLoS One (2016) 0.75
microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci U S A (2006) 8.24
Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. Proc Natl Acad Sci U S A (2008) 4.79
miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer. Cancer Biol Ther (2007) 3.93
An extended consensus motif enhances the specificity of substrate modification by SUMO. EMBO J (2006) 1.86
Integrative genomic analysis of protein kinase C (PKC) family identifies PKCiota as a biomarker and potential oncogene in ovarian carcinoma. Cancer Res (2006) 1.70
Tumor vascular proteins as biomarkers in ovarian cancer. J Clin Oncol (2007) 1.55
Distinct region-specific alpha-synuclein oligomers in A53T transgenic mice: implications for neurodegeneration. J Neurosci (2010) 1.49
Integrative genomic analysis of phosphatidylinositol 3'-kinase family identifies PIK3R3 as a potential therapeutic target in epithelial ovarian cancer. Clin Cancer Res (2007) 1.48
Distinct roles for the catalytic and hemopexin domains of membrane type 1-matrix metalloproteinase in substrate degradation and cell migration. J Biol Chem (2004) 1.44
Redirected antitumor activity of primary human lymphocytes transduced with a fully human anti-mesothelin chimeric receptor. Mol Ther (2011) 1.35
Chimeric antigen receptor T Cells with dissociated signaling domains exhibit focused antitumor activity with reduced potential for toxicity in vivo. Cancer Immunol Res (2013) 1.28
Reactive oxygen species and HIF-1 signalling in cancer. Cancer Lett (2008) 1.21
Environmental factors and genetic susceptibility promote urinary bladder cancer. Toxicol Lett (2010) 1.20
Specificity determinants in MAPK signaling to transcription factors. J Biol Chem (2002) 1.20
Metal-induced carcinogenesis, oxidative stress and hypoxia signalling. Mutat Res (2008) 1.12
Novel recombinant human b7-h4 antibodies overcome tumoral immune escape to potentiate T-cell antitumor responses. Cancer Res (2013) 1.11
Furin directly cleaves proMMP-2 in the trans-Golgi network resulting in a nonfunctioning proteinase. J Biol Chem (2005) 1.05
Primary human ovarian epithelial cancer cells broadly express HER2 at immunologically-detectable levels. PLoS One (2012) 1.04
The S18Y polymorphic variant of UCH-L1 confers an antioxidant function to neuronal cells. Hum Mol Genet (2008) 0.98
ERK5 is targeted to myocyte enhancer factor 2A (MEF2A) through a MAPK docking motif. Biochem J (2004) 0.97
Effective survival of immobilized Lactobacillus casei during ripening and heat treatment of probiotic dry-fermented sausages and investigation of the microbial dynamics. Meat Sci (2013) 0.97
miRNA genetic alterations in human cancers. Expert Opin Biol Ther (2007) 0.94
miR-Sens--a retroviral dual-luciferase reporter to detect microRNA activity in primary cells. RNA (2012) 0.93
Novel surface targets and serum biomarkers from the ovarian cancer vasculature. Cancer Biol Ther (2011) 0.91
Transcriptional regulation of PIK3CA oncogene by NF-kappaB in ovarian cancer microenvironment. PLoS One (2008) 0.88
Mutational spectrum of APC and genotype-phenotype correlations in Greek FAP patients. BMC Cancer (2010) 0.85
TAF4b and Jun/activating protein-1 collaborate to regulate the expression of integrin alpha6 and cancer cell migration properties. Mol Cancer Res (2010) 0.84
Distinct adhesion of probiotic strain Lactobacillus casei ATCC 393 to rat intestinal mucosa. Anaerobe (2012) 0.84
Effect of probiotic-fermented milk administration on gastrointestinal survival of Lactobacillus casei ATCC 393 and modulation of intestinal microbial flora. J Mol Microbiol Biotechnol (2010) 0.83
Monitoring survival of Lactobacillus casei ATCC 393 in probiotic yogurts using an efficient molecular tool. J Dairy Sci (2013) 0.81
Tumor vascular biomarkers: new opportunities for cancer diagnostics. Cancer Biomark (2011) 0.81
Reactive oxygen species (ROS) in multistage carcinogenesis. Cancer Lett (2008) 0.81
Silibinin protects H9c2 cardiac cells from oxidative stress and inhibits phenylephrine-induced hypertrophy: potential mechanisms. J Nutr Biochem (2012) 0.81
A new methodology for rapid detection of Lactobacillus delbrueckii subsp. bulgaricus based on multiplex PCR. J Microbiol Methods (2010) 0.80
Rapid detection and identification of probiotic Lactobacillus casei ATCC 393 by multiplex PCR. J Mol Microbiol Biotechnol (2010) 0.80
Mannose receptor (MR) engagement by mesothelin GPI anchor polarizes tumor-associated macrophages and is blocked by anti-MR human recombinant antibody. PLoS One (2011) 0.80
Hereditary cancer syndromes. J BUON (2007) 0.78
Differential effects of Parkin and its mutants on protein aggregation, the ubiquitin-proteasome system, and neuronal cell death in human neuroblastoma cells. J Neurochem (2007) 0.77
Screening of the DNA mismatch repair genes MLH1, MSH2 and MSH6 in a Greek cohort of Lynch syndrome suspected families. BMC Cancer (2010) 0.77
The organomercurial 4-aminophenylmercuric acetate, independent of matrix metalloproteinases, induces dose-dependent activation/inhibition of platelet aggregation. Thromb Haemost (2005) 0.76
Endocrine disruption effects of p,p'-DDE on juvenile zebrafish. J Appl Toxicol (2014) 0.75
Editorial: The microRNA 221/222 Cluster: Inaugurating a New Era in Cardiovascular Disease and Cancer? Curr Vasc Pharmacol (2016) 0.75